O'Grady A - Search Results

1

The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkers.

Foley R, Marignol L, Thomas AZ, Cullen IM, Perry AS, Tewari P, O'Grady A, Kay E, Dunne B, Loftus B, Watson WR, Fitzpatrick JM, Woodson K, Lehman T, Hollywood D, Lynch TH, Lawler M. Foley R, et al. Cancer Biol Ther. 2009 Jan;8(2):118-24. doi: 10.4161/cbt.8.2.7086. Epub 2009 Feb 1. Cancer Biol Ther. 2009. PMID: 19106642

2

Inter-observer variation of p53 immunohistochemistry--an assessment of a practical problem and comparison with other studies.

Kay EW, Barry Walsh CJ, Whelan D, O'Grady A, Leader MB. Kay EW, et al. Br J Biomed Sci. 1996 Jun;53(2):101-7. Br J Biomed Sci. 1996. PMID: 8757686

3

p53 mutations in squamous cell carcinomas from renal transplant recipients.

Bennett MA, O'Grady A, Kay EW, Leader M, Murphy GM. Bennett MA, et al. Biochem Soc Trans. 1997 Feb;25(1):342-5. doi: 10.1042/bst0250342. Biochem Soc Trans. 1997. PMID: 9056896 No abstract available.

4

p53 tumor suppressor gene protein expression in premalignant and malignant skin lesions of kidney transplant recipients.

Gibson GE, O'Grady A, Kay EW, Leader M, Murphy GM. Gibson GE, et al. J Am Acad Dermatol. 1997 Jun;36(6 Pt 1):924-31. doi: 10.1016/s0190-9622(97)80274-5. J Am Acad Dermatol. 1997. PMID: 9204056

5

Low-dose retinoid therapy for chemoprophylaxis of skin cancer in renal transplant recipients.

Gibson GE, O'Grady A, Kay EW, Murphy GM. Gibson GE, et al. J Eur Acad Dermatol Venereol. 1998 Jan;10(1):42-7. J Eur Acad Dermatol Venereol. 1998. PMID: 9552756 Clinical Trial.

6

Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy.

Gibson GE, O'Grady A, Kay EW, Leader M, Murphy GM. Gibson GE, et al. J Eur Acad Dermatol Venereol. 1998 Mar;10(2):130-6. J Eur Acad Dermatol Venereol. 1998. PMID: 9553909 Clinical Trial.

7

Altered expression of the p53-regulated proteins, p21Waf1/Cip1, MDM2, and Bax in ultraviolet-irradiated human skin.

O'Grady A, Kay EW, McKenna DB, Bennett MA, Murphy GM, Leader MB. O'Grady A, et al. Hum Pathol. 1998 Jun;29(6):559-64. doi: 10.1016/s0046-8177(98)80003-8. Hum Pathol. 1998. PMID: 9635674

8

Expression of CD44 in uterine cervical squamous neoplasia: a predictor of microinvasion?

Callagy G, O'Grady A, Butler D, Leader M, Kay E. Callagy G, et al. Gynecol Oncol. 2000 Jan;76(1):73-9. doi: 10.1006/gyno.1999.5661. Gynecol Oncol. 2000. PMID: 10620445

9

Prognostic relevance of Fas (APO-1/CD95) ligand in human colorectal cancer.

Sheehan KM, O'Donovan DG, Fitzmaurice G, O'Grady A, O'Donoghue DP, Sheahan K, Byrne MF, Conroy RM, Kay EW, Murray FE. Sheehan KM, et al. Eur J Gastroenterol Hepatol. 2003 Apr;15(4):375-80. doi: 10.1097/00042737-200304000-00007. Eur J Gastroenterol Hepatol. 2003. PMID: 12655257

10

HER-2 analysis in tissue microarrays of archival human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization.

O'Grady A, Flahavan CM, Kay EW, Barrett HL, Leader MB. O'Grady A, et al. Appl Immunohistochem Mol Morphol. 2003 Jun;11(2):177-82. doi: 10.1097/00129039-200306000-00016. Appl Immunohistochem Mol Morphol. 2003. PMID: 12778005

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page